Patent · US Active

Pyrimidine FGFR4 inhibitors

US9730931B2 · kind B2 · utility

5Cited by
3References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 27, 2016
Grant dateAug 15, 2017
Priority date—
Expiry dateJul 27, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compounds of Formula I useful as FGFR4 inhibitors, as well as methods of use of the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.